The biggest changes are increases to Medicare costs, experts said, with monthly premiums rising from about $185 per person in 2025 to $202.90 per person in 2026.

Medicare enrollees will save more than 50% on out-of-pocket costs for 10 common prescription drugs under their insurance plans, AARP said.

Americans enrolled in Medicare will pay about 50% less out of pocket in 2026 for some drugs including Pfizer and Bristol Myers Squibb's blood thinner Eliquis and Merck & Co's diabetes drug Januvia, a study in the five most populous U.

Your initial window to enroll in Medicare starts three months before the month of your 65th birthday and ends three months after that month. And if you're late enrolling in Medicare, you could face steep lifelong surcharges on your Part B premiums.

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP.

Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mixed benefits for patients while costing Medicare billions of dollars, reveals research published in the journal BMJ Medicine.

The reclassification would move marijuana away from its current classification as a Schedule I drug, alongside heroin and LSD. Cannabis would instead be a Schedule III substance, like ketamine and some anabolic steroids.

The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing out-of-pocket drug costs under the Medicare healthcare program for older and disabled Americans to prices on par with economically comparable countries.

Health insurance costs are expected to rise in 2026 as ACA subsidies expire and new rules take effect. Here's what enrollees need to know.

Senior Tennessee residents using TennCare could see lower drug prices starting on Jan. 1. but prices could increase elsewhere due to ACA cuts.

The U.S. Department of Health and Human Services announced new rules that restrict transgender minors' access to gender-affirming care.